Jacobs Levy Equity Management
SGHT icon

Jacobs Levy Equity Management’s Sight Sciences SGHT Stock Holding History

Jacobs Levy Equity Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
327,912
+313,866
+2,235% +$1.69M 0.01% 677
2025
Q4 		$111K Buy
+14,046
New +$89.7K ﹤0.01% 905
2025
Q2 		– Sell
-10,047
Closed -$24.1K – 1150
2025
Q1 		$24.1K Sell
10,047
-62,578
-86% -$176K ﹤0.01% 1058
2024
Q4 		$264K Sell
72,625
-135,268
-65% -$616K ﹤0.01% 882
2024
Q3 		$1.31M Buy
207,893
+65,767
+46% +$443K 0.01% 680
2024
Q2 		$948K Sell
142,126
-234,931
-62% -$1.39M ﹤0.01% 755
2024
Q1 		$1.99M Buy
377,057
+76,549
+25% +$360K 0.01% 598
2023
Q4 		$1.55M Buy
+300,508
New +$927K 0.01% 648
2023
Q3 		– Sell
-43,363
Closed -$359K – 1055
2023
Q2 		$359K Buy
+43,363
New +$390K ﹤0.01% 858

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jacobs Levy Equity Management's SGHT Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Sight Sciences (SGHT) stake by 2,235% in Q1 2026, buying an estimated $1.69M and bringing the position to 327,912 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #677.

Jacobs Levy Equity Management first reported a position in SGHT in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.99M in Q1 2024. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Jacobs Levy Equity Management held 327,912 shares of Sight Sciences worth $1.24M as of Q1 2026.
  • Jacobs Levy Equity Management bought 313,866 Sight Sciences shares in Q1 2026, an estimated $1.69M.
  • Sight Sciences made up 0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #677 holding.
  • Jacobs Levy Equity Management first reported a position in Sight Sciences in Q2 2023 and has held it in 9 quarters since.
  • Jacobs Levy Equity Management's Sight Sciences position peaked at $1.99M in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.